Medical Patent Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Patents
Study results from National Institute of Pharmaceutical Education and Research broaden understanding of patents
April 11th, 2007
A new study, "Recent advances in antimalarial compounds and their patents," is now available. According to recent research published in the journal Current Medicinal Chemistry, "Malaria is one of the most severe tropical parasitic disease causing 1-3 million deaths annually. In the last 25 years very few new antimalarial molecules have been developed and only a limited number of them are currently in various stages of clinical development." "The presently available antimalarial drugs include artemisinin analogs, quinoline derivatives and antifolates. This review summarizes recent advances in antimalarial drug development and world patents published between...
Source: Medical Patent Law Weekly (2007-04-11)
|
